Yuyan Bao

773 total citations · 1 hit paper
22 papers, 579 citations indexed

About

Yuyan Bao is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuyan Bao has authored 22 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuyan Bao's work include DNA Repair Mechanisms (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and MicroRNA in disease regulation (2 papers). Yuyan Bao is often cited by papers focused on DNA Repair Mechanisms (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and MicroRNA in disease regulation (2 papers). Yuyan Bao collaborates with scholars based in China, Germany and Pakistan. Yuyan Bao's co-authors include Xiaoqiang Huang, Yuanyuan Xu, Chuan Li, Zhongyuan Liu, Jun Cao, Changlin Tian, Hongwei Chen, Yue Zhao, Zhongqiu Xing and Xiaoping Jin and has published in prestigious journals such as Nature, Scientific Reports and Food Chemistry.

In The Last Decade

Yuyan Bao

20 papers receiving 574 citations

Hit Papers

A light-driven enzymatic enantioselective radical acylation 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuyan Bao China 12 273 111 99 63 56 22 579
Maciej Małecki Poland 14 280 1.0× 67 0.6× 91 0.9× 52 0.8× 97 1.7× 83 732
Zhen Fang China 16 382 1.4× 86 0.8× 142 1.4× 80 1.3× 65 1.2× 42 685
Shu‐Ping Wang China 17 484 1.8× 101 0.9× 125 1.3× 45 0.7× 75 1.3× 36 919
Beiying Qiu Singapore 17 549 2.0× 82 0.7× 82 0.8× 27 0.4× 74 1.3× 32 883
Joshua A. Dubland Canada 12 262 1.0× 64 0.6× 107 1.1× 40 0.6× 74 1.3× 17 792
Min Lv China 13 376 1.4× 67 0.6× 168 1.7× 69 1.1× 69 1.2× 25 598
Murali K. Akula Sweden 7 489 1.8× 66 0.6× 182 1.8× 42 0.7× 101 1.8× 10 748
Lina Yin China 21 310 1.1× 236 2.1× 119 1.2× 143 2.3× 146 2.6× 37 1.0k
Joshua R. Sacher United States 12 349 1.3× 102 0.9× 156 1.6× 169 2.7× 73 1.3× 18 619

Countries citing papers authored by Yuyan Bao

Since Specialization
Citations

This map shows the geographic impact of Yuyan Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuyan Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuyan Bao more than expected).

Fields of papers citing papers by Yuyan Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuyan Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuyan Bao. The network helps show where Yuyan Bao may publish in the future.

Co-authorship network of co-authors of Yuyan Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Yuyan Bao. A scholar is included among the top collaborators of Yuyan Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuyan Bao. Yuyan Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Linna, Muliang Jiang, Yuyan Bao, et al.. (2025). Enzyme-free nano-sensor for high-sensitivity miRNA detection and tumor imaging based on multicolor silver nanoclusters pair and DNA-mediated CHA reactions. Sensors and Actuators B Chemical. 427. 137222–137222. 4 indexed citations
2.
Bao, Yuyan, Bing Hong, Kaiping Liu, et al.. (2025). Berberine derivative C51 modulates cGAS-STING-TIM-3 axis to reverse immune evasion and inhibit lung cancer growth. Cellular Signalling. 139. 112258–112258.
3.
Wang, Chunyue, Tao Wang, Xuan Zhang, et al.. (2024). The FGG c.952G>A variant causes congenital dysfibrinogenemia characterized by recurrent cerebral infarction: a case report. Frontiers in Neurology. 15. 1272802–1272802.
4.
Wu, Yaping, et al.. (2024). Salvianolic Acid B Ameliorated Chemotherapeutic Injury of Cardiac Myocytes through the Nrf2/ARE Signaling Pathway. Discovery Medicine. 36(181). 415–415. 1 indexed citations
5.
Tang, Hongmei, et al.. (2024). Nucleic acid-functionalized gold nanoparticles as intelligent photothermal therapy agents for precise cancer treatment. Nanotechnology. 35(46). 465101–465101. 6 indexed citations
6.
Xu, Yuanyuan, Hongwei Chen, Lu Yu, et al.. (2023). A light-driven enzymatic enantioselective radical acylation. Nature. 625(7993). 74–78. 123 indexed citations breakdown →
7.
Bao, Yuyan, Yuanyuan Xu, & Xiaoqiang Huang. (2023). Focused rational iterative site-specific mutagenesis (FRISM): A powerful method for enzyme engineering. Molecular Catalysis. 553. 113755–113755. 34 indexed citations
8.
Weng, Qiaoyou, Hailin Wang, Jiansheng Huang, et al.. (2021). Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy. Frontiers in Oncology. 11. 590937–590937. 13 indexed citations
9.
Liu, Qian, Hao Yan, Lili Fu, et al.. (2021). A novel indazole derivative, compound Cyy-272, attenuates LPS-induced acute lung injury by inhibiting JNK phosphorylation. Toxicology and Applied Pharmacology. 428. 115648–115648. 3 indexed citations
10.
Bao, Yuyan, Lei Qiao, Yanyan Hu, et al.. (2021). KIF18b-dependent hypomethylation of PARPBP gene promoter enhances oxaliplatin resistance in colorectal cancer. Experimental Cell Research. 407(2). 112827–112827. 11 indexed citations
12.
Lin, Zhenjian, et al.. (2021). Salvianolic acid B attenuated cisplatin-induced cardiac injury and oxidative stress via modulating Nrf2 signal pathway. The Journal of Toxicological Sciences. 46(5). 199–207. 18 indexed citations
13.
14.
He, Ye, Shuibin Wang, Song Soo Yang, et al.. (2019). MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis. Clinical & Translational Oncology. 22(1). 111–121. 67 indexed citations
15.
He, Xinwei, et al.. (2018). Longitudinal evaluation of serum periostin levels in patients after large-artery atherosclerotic stroke: A prospective observational study. Scientific Reports. 8(1). 11729–11729. 11 indexed citations
16.
Fang, Zejun, Chaoju Gong, Weihua Zhou, et al.. (2017). NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling. Cancer Letters. 415. 58–72. 56 indexed citations
17.
He, Xinwei, Yuyan Bao, Weijun Hong, et al.. (2017). Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke. Clinica Chimica Acta. 478. 157–161. 20 indexed citations
18.
Weng, Qiaoyou, Yan Hu, Haixia Zhou, et al.. (2016). Curcumin analogue, A13, exhibits anti-leukemia effect via inhibiting STAT3. Tumor Biology. 37(7). 9959–9966. 5 indexed citations
19.
He, Xinwei, En Wang, Yuyan Bao, et al.. (2016). High serum levels of sclerostin and Dickkopf-1 are associated with acute ischaemic stroke. Atherosclerosis. 253. 22–28. 46 indexed citations
20.
Zeng, Qinghua, Yong Hwan Han, Yuyan Bao, et al.. (2010). 20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 299(4). H1109–H1117. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026